Navigation Links
Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2012
Date:1/25/2012

ts, including those located in Japan; the company's ability to maintain or increase margins; the impact of competitive products and pricing; the potential loss of key distributors or key personnel; challenges to public tender awards and the loss of such awards or other orders; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

A summary of earnings and other financial information follows.Varian Medical Systems, Inc. and Subsidiaries Consolidated Statements of Earnings
(Unaudited)(Dollars and shares in millions, except per share amounts)Q1 QTR2012Q1 QTR2011Net orders

$

606.1$

592.8  Oncology Systems484.7459.0  X-Ray Products109.8111.9  Security & Inspection Products10.821.3  Varian Particle Therapy 0.60.6  Ginzton Technology Center 0.2-Order backlog

$

2,510.2$

2,205.6Revenues    

$

625.3$

579.9  Oncology Systems487.6452.4  X-Ray Products113.0111.6  Other24.715.9Cost  of  revenues

$

356.5$

313.1Gross margin   268.8266.8
As a percent of revenues
43.0%46.0%Operating expenses    Research and development43.838.5  Selling, general and administrative  96.191.3Operating earnings128.9137.0
As a percent of revenues
20.6%23.6%Interest income, net0.30.1Earnings before taxes129.2137.1Taxes on earnings  39.040.6Net earnings  

$

90.2$

96.5   As a percent of revenues14.4%16.6%Net earnings per share – basic

$

0.80$

0.82Net ear
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... ROCKVILLE, Md. , July 29, 2014  Synthetic ... anti-infective biologic and drug candidates targeting specific pathogens that ... view of the unusual market activity in the Company,s ... Company in accordance with its usual practice. The Company ... unusual market activity. About Synthetic Biologics, Inc. ...
(Date:7/29/2014)... -- New high priced hepatitis C drugs will increase ... $2.9 to $5.8 billion next year, according to a ... by the Pharmaceutical Care Management Association (PCMA). Milliman projects ... much as 8.6 percent in 2015 as a result ... The study finds that the majority of ...
(Date:7/29/2014)... ALBANY, New York , July 29, 2014 /PRNewswire/ ... published by Transparency Market Research "Surgical Navigation Systems Market ... Systems) - Global Industry Analysis, Size, Share, Growth, Trends ... systems market was valued at USD 218.5 million in ... of 4.5% from 2014 to 2020, to reach an ...
Breaking Medicine Technology:Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 4
(Date:7/29/2014)... (PRWEB) July 29, 2014 Outsourced ... of tripling in the number of hospitals contracting ... 1, 2015 deadline, according to the recently published ... physician leaders, found in the reports “Top Ranked ... hospitals now outsource Clinical documentation audit, review and ...
(Date:7/29/2014)... million this year to support innovative research on ... that affect more than 233,000 Canadians. , ... across Canada. This diverse research will explore genetic ... understanding (and potential treatment) of symptoms and consider ... life. , Crohn,s and Colitis Canada funds ...
(Date:7/29/2014)... 29, 2014 CHI-California Healthcare Institute today ... the hepatitis C (hep C) epidemic in the U.S., ... treatments to reduce human suffering. The report examines key ... of hep C, while highlighting the significance of breakthroughs ... treatment. CHI is a nonprofit, public policy research organization, ...
(Date:7/29/2014)... Dennis Thompson HealthDay Reporter ... deadly Ebola virus that continues to rage throughout West Africa ... Ebola only spreads through physical touch, and it can,t ... Stephan Monroe, deputy director of the National Center for Emerging ... Control and Prevention, explained in a Monday afternoon news conference. ...
(Date:7/29/2014)... and aptitudes of Vietnam War veterans who suffered penetrating ... and beginning to answer -- longstanding questions about how ... regions that contribute to optimal social functioning also are ... finding bolsters the view that general intelligence emerges from ... , The findings are reported in the ...
Breaking Medicine News(10 mins):Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 3Health News:Prestigious Crohn's and Colitis Canada grants fund promising Canadian research 2Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 2Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 3Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 4Health News:CDC Downplays Ebola's Threat to the United States 2Health News:CDC Downplays Ebola's Threat to the United States 3Health News:CDC Downplays Ebola's Threat to the United States 4Health News:Team studies the social origins of intelligence in the brain 2Health News:Team studies the social origins of intelligence in the brain 3
... have found a set of "master switches" that keep ... the switches' code may one day enable scientists to ... cancer and other bone marrow disorders. ,The ... level, but farther down the protein production line in ...
... improve their infrastructure to prevent and manage outbreaks of dengue. ... Health Organisation (WHO) meeting to chart a roadmap to improve ... is a prevailing disease for the past two to three ... ,The WHO says the frequency of dengue outbreaks ...
... HIV Vaccine Trials Network (HVTN) this week launched the African ... (Ad5 gag/pol/nef) vaccine. The investigators hope to enroll 3,000 HIV-negative ... to last four years. ,The first Phase IIb ... the Caribbean and Australia in 2005, and was known as ...
... of Current Directions in Psychological Science suggests that the ... genes during post-copulation as well, a phenomenon dubbed "sperm ... Aaron Getz at Florida Atlantic University describe sperm competition ... ,For a monogamous species, sperm competition ...
... the viability of an approach to routinely detect the ... accurately diagnose or rule// out genetic defects - as ... presented at the 27th Annual Meeting of the Society ... ,This future diagnostic technology, currently under ...
... a group of Spanish scientists, amongst which were members ... and the Centre for Applied Medical Research// (CIMA) of ... of treatment for patients with acute lymphoblastic leukemia. ... in the official journal, Blood, of the American Haematology ...
Cached Medicine News:Health News:Master Switches Found for Adult Blood Stem Cells 2Health News:WHO Urges Asian Countries To Improve Infrastructure To Tackle Dengue 2Health News:Largest Ever African HIV Vaccine Trial Opens in South Africa 2Health News:Males Adapt To Battle With Competing Sperm 2Health News:New Approach to Routine Prenatal Genetic Testing 2Health News:A New Treatment Discovered For Acute Lymphoblastic Leukemia 2
... an automatic petri dish streaking machine. ... up to 180 pre inoculated petri ... in substantial cost savings. The ISOPLATER® ... standardizes streaking procedures and increases safety ...
Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
A compact mobile System Cart gives mobility within your department. The cart accomodates the Uromac Median data processor, desktop computer, printer and provides stowage space. Patient related transd...
... for any clinical setting, offering an ... UDS procedure. Customize Delphis™ to your ... a Pocket PC, a Touchpad PC ... wireless technology allows you to focus ...
Medicine Products: